Physiomics Plc (PYC) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.514x

Based on the latest financial reports, Physiomics Plc (PYC) has a cash flow conversion efficiency ratio of -0.514x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-202.00K ≈ $-24.58 USD) by net assets (GBX393.00K ≈ $47.82 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Physiomics Plc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Physiomics Plc - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Physiomics Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Physiomics Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Physiomics Plc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Chordate Medical Holding AB ST:CMH	-0.514x
Anemoi International Ltd LSE:AMOI	-0.089x
World Chess PLC LSE:CHSS	0.034x
PHILION SE O.N. F:PH6	N/A
Alina Holdings PLC LSE:ALNA	-0.041x
WICKET GAMING AB F:7Q4	0.015x
Sonder Holdings Inc NASDAQ:SOND	0.040x
Hsin Yung Chien Co Ltd TW:2114	0.010x

Annual Cash Flow Conversion Efficiency for Physiomics Plc (2001–2025)

The table below shows the annual cash flow conversion efficiency of Physiomics Plc from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Physiomics Plc (PYC) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	GBX692.17K ≈ $84.22	GBX-546.14K ≈ $-66.45	-0.789x	+59.33%
2024-06-30	GBX282.53K ≈ $34.38	GBX-548.13K ≈ $-66.69	-1.940x	-289.48%
2023-06-30	GBX531.72K ≈ $64.69	GBX-264.86K ≈ $-32.23	-0.498x	-39.03%
2022-06-30	GBX974.81K ≈ $118.61	GBX-349.25K ≈ $-42.49	-0.358x	-1185.23%
2021-06-30	GBX1.17 Million ≈ $141.83	GBX-32.50K ≈ $-3.95	-0.028x	+68.31%
2020-06-30	GBX1.31 Million ≈ $160.00	GBX-115.69K ≈ $-14.08	-0.088x	+62.80%
2019-06-30	GBX607.91K ≈ $73.97	GBX-143.77K ≈ $-17.49	-0.237x	+3.89%
2018-06-30	GBX690.03K ≈ $83.96	GBX-169.80K ≈ $-20.66	-0.246x	+81.53%
2017-06-30	GBX328.25K ≈ $39.94	GBX-437.27K ≈ $-53.20	-1.332x	+21.60%
2016-06-30	GBX204.15K ≈ $24.84	GBX-346.87K ≈ $-42.20	-1.699x	-40.90%
2015-06-30	GBX325.62K ≈ $39.62	GBX-392.65K ≈ $-47.77	-1.206x	+53.18%
2014-06-30	GBX136.49K ≈ $16.61	GBX-351.51K ≈ $-42.77	-2.575x	-25.62%
2013-06-30	GBX255.82K ≈ $31.13	GBX-524.49K ≈ $-63.81	-2.050x	-172.94%
2012-06-30	GBX734.57K ≈ $89.38	GBX-551.77K ≈ $-67.13	-0.751x	+11.68%
2011-06-30	GBX756.00K ≈ $91.98	GBX-643.00K ≈ $-78.23	-0.851x	-54.23%
2010-06-30	GBX787.00K ≈ $95.76	GBX-434.00K ≈ $-52.81	-0.551x	-80.29%
2009-06-30	GBX-85.00K ≈ $-10.34	GBX26.00K ≈ $3.16	-0.306x	-188.03%
2008-06-30	GBX-354.00K ≈ $-43.07	GBX-123.00K ≈ $-14.97	0.347x	+108.89%
2007-06-30	GBX99.00K ≈ $12.05	GBX-387.00K ≈ $-47.09	-3.909x	-194.51%
2006-06-30	GBX-66.00K ≈ $-8.03	GBX-273.00K ≈ $-33.22	4.136x	+499.14%
2005-06-30	GBX413.00K ≈ $50.25	GBX-428.00K ≈ $-52.08	-1.036x	-268.28%
2004-06-30	GBX-354.00K ≈ $-43.07	GBX-218.00K ≈ $-26.52	0.616x	-60.87%
2003-06-30	GBX-129.00K ≈ $-15.70	GBX-203.00K ≈ $-24.70	1.574x	+233.71%
2001-06-30	GBX130.00K ≈ $15.82	GBX-153.00K ≈ $-18.62	-1.177x	--

About Physiomics Plc

LSE:PYC UK Biotechnology

Market Cap

$28.95K

GBX237.93 Million GBX

Market Cap Rank

#31493 Global

#1250 in UK

Share Price

GBX0.53

Change (1 day)

+10.53%

52-Week Range

GBX0.27 - GBX0.70

All Time High

GBX17.13